NCT05683678 2025-04-04
US Selumetinib Registry
Alexion Pharmaceuticals, Inc.
Terminated
Clinical Trials
10 trialsNCT04800822 2024-10-22
PF-07284892 in Participants With Advanced Solid Tumors
Pfizer
Phase 1 Terminated
NCT03504501 2023-11-30
SynCoRAS
Technical University of Munich
Phase 2 Terminated
NCT01968590 2022-05-25
VitDBoneNF1
University of Utah
Phase 2 Terminated
NCT02387840 2021-01-12
Feasibility and Clinically Application of Magnetic Resonance Fingerprinting
Case Comprehensive Cancer Center
Phase NA Terminated
NCT02256124 2020-04-14
NF1-EXCEL
Erasmus Medical Center
Phase 2/3 Terminated
NCT02584413 2019-09-03
Hypotonia and Neurofibromatosis Type 1 (NF1) Glioma
Washington University School of Medicine
Phase NA Terminated
NCT00326872 2017-08-18
AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine
National Cancer Institute (NCI)
Phase 2 Terminated
NCT01365468 2016-05-12
Efficacy and Safety of RAD001 in Treating Plexiform Neurofibromas (PN) Associated With Neurofibromatosis (NF1)
Novartis
Phase 2 Terminated
NCT00060008 2014-04-04
Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma
Children's Hospital of Philadelphia
Phase NA Terminated